financetom
Business
financetom
/
Business
/
Canadian Large Cap Leaders Split Corp. Declares Distribution
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Canadian Large Cap Leaders Split Corp. Declares Distribution
Jun 20, 2025 11:12 AM

01:57 PM EDT, 06/20/2025 (MT Newswires) -- Canadian Large Cap Leaders Split Corp. (NPS.TO) on Friday declared a distribution payable on July 14 to Class A and Preferred shareholders (NPS.PR.A) of record at the close of business on June 30.

According to a company statement, the Class A holders will receive $0.125 per share, and Preferred shareholders receive $0.1875.

Price: 12.77, Change: +0.85, Percent Change: +7.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Johnson & Johnson Announces $6.48 Billion Plan for Unit to Resolve Ovarian Cancer Talc Claims
Update: Johnson & Johnson Announces $6.48 Billion Plan for Unit to Resolve Ovarian Cancer Talc Claims
May 1, 2024
10:15 AM EDT, 05/01/2024 (MT Newswires) -- (Updates to add detail of the plan in the second paragraph, more information in the third and fourth paragraphs and the company's latest stock move in the fifth paragraph.) Johnson & Johnson ( JNJ ) announced a proposed plan by its subsidiary, LLT Management, for the final resolution of all current and future...
--Citigroup Could See Big Hit to Loan Book From Heightened Climate Action Fight, Reuters Reports
--Citigroup Could See Big Hit to Loan Book From Heightened Climate Action Fight, Reuters Reports
May 1, 2024
10:44 AM EDT, 05/01/2024 (MT Newswires) -- Price: 61.30, Change: -0.03, Percent Change: -0.05 ...
Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial
Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial
May 1, 2024
10:44 AM EDT, 05/01/2024 (MT Newswires) -- Merck ( MRK ) said Wednesday that a phase 3 trial assessing its cancer drug Keytruda showed positive results in overall survival for patients with advanced gastric cancer. Merck ( MRK ) said Keytruda, in combination with trastuzumab and fluoropyrimidine- and platinum-containing chemotherapy, met its dual primary endpoint of overall survival in the...
Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal
Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal
May 1, 2024
10:44 AM EDT, 05/01/2024 (MT Newswires) -- Quest Diagnostics ( DGX ) and PathAI said Wednesday that Quest has agreed to acquire certain assets of PathAI Diagnostics as part of a wider collaboration. The transaction, which includes PathAI Diagnostics' digitized laboratory in Memphis, Tennessee, will close in Q2, according to a joint statement. Quest also agreed to use PathAI's digital...
Copyright 2023-2026 - www.financetom.com All Rights Reserved